Keros Therapeutics, Inc. (KROS) NASDAQ
10.55
-0.35(-3.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
10.55
-0.35(-3.21%)
Currency In USD
| Market Cap | 757.82M |
| Enterprise Value | 487.29M |
| P/E Ratio | -4.61 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 10.17 |
| Price/Book Ratio | 1.37 |
| Enterprise/Revenue | 2.18 |
| Enterprise/EBITDA | -0.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.57 |
| Operating Margin | -3.33 |
| Return On Assets | -0.27 |
| Return On Equity | -0.17 |
| Revenue | 244.06M |
| Revenue/Share | 0.89 |
| Gross Profit | 242.55M |
| EBITDA | 72.13M |
| Net Income | 87.01M |
| Diluted EPS | 2.3 |
| Total Cash | 281.5M |
| Total Cash/Share | 7.56 |
| Total Debt | 16.31M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 22.62 |
| Book Value Per Share | 7.67 |
| 52-Week Change | -28.04 |
| 52-Week High | 22.55 |
| 52-Week Low | 9.79 |
| Moving Average 50 Days | 11.38 |
| Moving Average 200 Days | 15.27 |
| Average Volume | 421,873 |
| Shares Outstanding | 32M |
| % Held by Institutions | 49.96 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |